Six-month compliance with antidepressant medication in the treatment of major depressive disorder

被引:54
|
作者
Demyttenaere, Koen [1 ]
Adelin, Albert [2 ]
Patrick, Mesters [3 ]
Walthere, Dewe [3 ]
Katrien, De Bruyckere
Michele, Sangeleer
机构
[1] Univ Hosp Gasthuisberg, Dept Psychiat, B-3000 Louvain, Belgium
[2] Univ Hosp, Dept Biostat, Ghent, Belgium
[3] Eli Lilly Mt St Guibert, European Dev Ctr, Mont St Guibert, Belgium
关键词
antidepressants; compliance; major depressive disorder;
D O I
10.1097/YIC.0b013e3282f1c1d8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The investigation of compliance in patients with major depressive disorder (in drop-outs versus completers and in first episode versus recurrent episode patients). A total of 85 outpatients with major depressive disorder were followed for 6 months. Different dimensions of compliance were investigated: drop-outs versus completers and their medication adherence (with electronic monitoring). General linear mixed models were applied to examine the time courses of adherence. Drop-out rates were higher in younger patients and in patients with a lower initial depression severity. The adherence during 6 months of treatment with selective serotonin reuptake inhibitors was above 80 in 70% of the patients. The adherence decreased by 2.5% per month and decreased more than three times more rapidly in drop-outs (from baseline to time of drop-out). A medical visit resulted in a temporary increase in pill intake. General linear mixed model analysis showed that the predicted outcome was worse in drop-outs than in completers and worse in recurrent episode patients than in first episode patients (the former showing a higher adherence). Adherence decreases with time during 6 months of treatment with antidepressants and is influenced by demographic and clinical variables. Completers show a higher adherence than drop-outs. The outcome was worse in recurrent episode patients than first episode patients although they had a higher adherence.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 50 条
  • [31] Six-Month Utilization of Psychotherapy by Older Adults with Depressive Symptoms
    Amber M. Gum
    Anne Hirsch
    Natalie D. Dautovich
    Stephen Ferrante
    Lawrence Schonfeld
    Community Mental Health Journal, 2014, 50 : 759 - 764
  • [32] Six-Month Utilization of Psychotherapy by Older Adults with Depressive Symptoms
    Gum, Amber M.
    Hirsch, Anne
    Dautovich, Natalie D.
    Ferrante, Stephen
    Schonfeld, Lawrence
    COMMUNITY MENTAL HEALTH JOURNAL, 2014, 50 (07) : 759 - 764
  • [33] EVALUATION OF FACTORS INFLUENCING ANTIDEPRESSANT MEDICATION COMPLIANCE IN OUTPATIENT TREATMENT OF DEPRESSIVE DISORDERS IN KOREA
    Moon-Soo, L.
    Jae-Won, Y.
    Hyonggin, A.
    Seung-Hyun, K.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [34] Rumination in patients with major depressive disorder before and after antidepressant treatment
    Segerberg, T.
    Ozenne, B.
    Dam, V. H.
    Kohler-Forsberg, K.
    Jorgensen, M. B.
    Frokjaer, V. G.
    Knudsen, G. M.
    Stenbaek, D. S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S530 - S530
  • [35] Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder
    Cullen, Kathryn R.
    Klimes-Dougan, Bonnie
    Dung Pham Vu
    Schreiner, Melinda Westlund
    Mueller, Bryon A.
    Eberly, Lynn E.
    Camchong, Jazmin
    Westervelt, Ana
    Lim, Kelvin O.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 705 - 712
  • [36] Serotonin Transporter Gene Methylation and Antidepressant Treatment of Major Depressive Disorder
    Lisoway, Amanda
    Zai, Clement C.
    Tiwari, Arun K.
    Harripaul, Ricardo
    Freeman, Natalie
    Oh, Gabriel
    French, Leon
    Kaminsky, Zachary A.
    Kennedy, James
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S95 - S95
  • [37] Imaging the serotonin transporter during major depressive disorder and antidepressant treatment
    Meyer, Jeffrey H.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2007, 32 (02): : 86 - 102
  • [38] Rumination in patients with major depressive disorder before and after antidepressant treatment
    Segerberg, Tina S. S.
    Ozenne, Brice
    Dam, Vibeke H.
    Kohler-Forsberg, Kristin
    Jorgensen, Martin B.
    Frokjaer, Vibe G.
    Knudsen, Gitte M.
    Stenbaek, Dea S.
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 360 : 322 - 325
  • [39] The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder
    Reed, Carol R.
    Kajdasz, Daniel K.
    Whalen, Heidi
    Athanasiou, Maria C.
    Gallipoli, Susan
    Thase, Michael E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 27 - 39
  • [40] Heterogeneity in Antidepressant Treatment and Major Depressive Disorder Outcomes Among Clinicians
    Rathnam, Sarah
    Hart, Kamber L.
    Sharma, Abhishek
    Verhaak, Pilar F.
    McCoy, Thomas H.
    Doshi-Velez, Finale
    Perlis, Roy H.
    JAMA PSYCHIATRY, 2024, 81 (10) : 1003 - 1009